N/A
N=179
Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care
Depression
Bottom Line
View on ClinicalTrials.gov: NCT00794196 ↗Enrolled (actual)
179
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcome: Primary: Adherence to Antidepressant Medication — 78.4; 61.9; 60.1; 40.2 percentage of adherence patients
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pharmaceutical care program for antidepressant treatment (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Fundació Sant Joan de Déu
- Primary completion
- Nov 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Antidepressant Medication |
78.4; 61.9; 60.1; 40.2 | — |
| SECONDARY Patient Wellbeing |
0.58; 0.66; 0.78; 0.79; 0.85; 0.80 | — |
Summary
The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.
Eligibility Criteria
Inclusion Criteria
- Clinical diagnosis for depression from a general practitioner
- Beginning a pharmacological antidepressant treatment
- Going to one of the participant community pharmacies
Exclusion Criteria
- Used antidepressant medication in the past 2 months
- Had an appointment with an specialist in mental disorders in the past 2 months
- History of psychotic or bipolar episodes
- History of drug abuse or dependency
- Cognitive impairment that not allows assessment
Data sourced from ClinicalTrials.gov (NCT00794196). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.